Patent · US Active

Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

US11413294B2 · kind B2 · utility

0Cited by

55References

15Claims

0Family size

Assignee

Ferring B.V. · NL

Inventors

Salah U. Ahmed · New City, US
Jiaxiang Tsao · Nanuet, US
Anu Mahashabde · Kendall Park, US
Diane D. Harrison · Villanova, US

Key dates

Filing date	Jan 31, 2020
Grant date	Aug 16, 2022
Priority date	—
Expiry date	Jan 31, 2040

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB29L2031/753
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.